FindTrial
Sign In

Detection of nucleic acid genotyping and drug-resistant gene mutations in Helicobacter pylori

Detection of nucleic acid genotyping and drug-resistant gene mutations in Helicobacter pylori

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016305
Enrollment
Unknown
Registered
2018-05-24
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gene typing and mutation of resistance gene of Helicobacter pylori

Interventions

Gold Standard:Drug Sensitivity Test
Index test:1.&#32
Helicobacter&#32
pylori&#32
resistance&#32
gene&#32
mutation&#32
assay&#32
kit(fluorescence&#32
PCR&#32
method)
2.&#32
genotyping&#32
kit(fluorescent&#32
method).

Sponsors

Beijing Geriatric Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Aged = 18 years old; 2. Patients with H. pylori infection who have been examined by gastroscope, or those who have tested positive for H. pylori by C13 urea exhalation and other experimental methods; 3. When choosing the previous gastric mucosal paraffin(FFPE) slice sample, should choose to use the paraffin section that has been preserved in the past three years.

Exclusion criteria

Exclusion criteria: 1. Didn't save according to regulations, or beyond the preservation period; 2. The extracted DNA OD value(OD260/OD280) is not between 1.6 and 2.0, and samples that can not be reextracted or purified to meet the requirements should be removed.

Design outcomes

Primary

MeasureTime frame
Gene;—

Countries

China

Contacts

Public ContactWanfa Fu

Beijing Geriatric Hospital

394766355@qq.com+86 010-62406644

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026